NCT00422240View on ClinicalTrials.gov

Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris

PHASE3CompletedINTERVENTIONAL
Enrollment

1,668

Participants

Timeline

Start Date

June 27, 2006

Primary Completion Date

July 12, 2007

Study Completion Date

July 12, 2007

Conditions
Acne Vulgaris
Interventions
DRUG

Adapalene/Benzoyl Peroxide

Adapalene 0.1 % \[weight by weight (W/W)\]/benzoyl peroxide 2.5 % (W/W) gel topically daily in the evening for 12 Weeks.

DRUG

Adapalene Gel, 0.1%

0.1% of adapalene gel topically daily in the evening for 12 Weeks.

DRUG

Benzoyl Peroxide Gel 2.5%

2.5% of benzoyl peroxide gel topically daily in the evening for 12 Weeks.

DRUG

Gel Vehicle

Participants were treated with gel vehicle topically daily in the evening for 12 Weeks.

Trial Locations (1)

78229

Miller MD, San Antonio

Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY